Nuveen, LLC Vanda Pharmaceuticals Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Nuveen, LLC holds 440,561 shares of VNDA stock, worth $2.02 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
440,561Holding current value
$2.02 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VNDA
# of Institutions
155Shares Held
44.1MCall Options Held
33.8KPut Options Held
28.7K-
Black Rock Inc. New York, NY8.14MShares$37.4 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.85MShares$17.7 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.5MShares$16 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.54MShares$11.7 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.35MShares$10.8 Million0.85% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $260M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...